The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.
Official Title: A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or Following Docetaxel-based Therapy.
Study ID: NCT01193257
Brief Summary: This is a randomized, double-blind, multicenter, phase 3 study evaluating orteronel plus prednisone compared with placebo plus prednisone in men with metastatic, castration-resistant prostate cancer (mCRPC) that has progressed following Docetaxel-based therapy
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
, Anchorage, Alaska, United States
, Fort Smith, Arkansas, United States
, Fountain Valley, California, United States
, Los Angeles, California, United States
, Riverside, California, United States
, San Diego, California, United States
, Fort Myers, Florida, United States
, Port Saint Lucie, Florida, United States
, Indianapolis, Indiana, United States
, Jeffersonville, Indiana, United States
, New Orleans, Louisiana, United States
, Westminster, Maryland, United States
, Detroit, Michigan, United States
, Jefferson City, Missouri, United States
, Las Vegas, Nevada, United States
, Hackensack, New Jersey, United States
, Albany, New York, United States
, East Syracuse, New York, United States
, Rochester, New York, United States
, Raleigh, North Carolina, United States
, Cincinnati, Ohio, United States
, Tualatin, Oregon, United States
, Lancaster, Pennsylvania, United States
, Pittsburgh, Pennsylvania, United States
, Greenville, South Carolina, United States
, Chattanooga, Tennessee, United States
, Nashville, Tennessee, United States
, Amarillo, Texas, United States
, Bedford, Texas, United States
, Dallas, Texas, United States
, Dallas, Texas, United States
, Odessa, Texas, United States
, Tyler, Texas, United States
, Webster, Texas, United States
, Salt Lake City, Utah, United States
, Newport News, Virginia, United States
, Kennewick, Washington, United States
, Redcliffe, Queensland, Australia
, Woodville South, South Australia, Australia
, Hobart, Tasmania, Australia
, Malvere, Victoria, Australia
, Wodonga, Victoria, Australia
, Brussels, , Belgium
, Kortijk, , Belgium
, Liege, , Belgium
, Namur, , Belgium
, Edmonton, Alberta, Canada
, Kelowna, British Columbia, Canada
, Moncton, New Brunswick, Canada
, Brampton, Ontario, Canada
, Newmarket, Ontario, Canada
, Greenfield Park, Quebec, Canada
, Montreal, Quebec, Canada
, Pointe-Claire, Quebec, Canada
, Hradec Dralove, , Czechia
, Kromertz, , Czechia
, Modrice, , Czechia
, Praha, , Czechia
, Zlin, , Czechia
, Tallinn, , Estonia
, Oulu, , Finland
, Tampere, , Finland
, La Roche-sur-Yon, , France
, Le Mans, , France
, Lyon Cedex, , France
, Lyon, , France
, Marseille, , France
, Paris, , France
, Villejuif cedex, , France
, Patras, , Greece
, Miskolc, , Hungary
, Osztaly, , Hungary
, Novara, , Italy
, Rome, , Italy
, Eindhoven, , Netherlands
, Bielsko-Biala, , Poland
, Goczalkowice-Zdroj, , Poland
, Wroclaw, , Poland
, Sevilla, , Spain
Name: Medical Monitor
Affiliation: Millennium Pharmaceuticals, Inc.
Role: STUDY_DIRECTOR